Get the Stockscreener App
1.82
0.55%
-0.01
After Hours:
1.85
0.03
+1.65%
Cardio Diagnostics Holdings Inc stock is traded at $1.82, with a volume of 56,020.
It is down -0.55% in the last 24 hours and down -8.08% over the past month.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
See More
Previous Close:
$1.83
Open:
$1.83
24h Volume:
56,020
Relative Volume:
0.02
Market Cap:
$5.39M
Revenue:
$14,800
Net Income/Loss:
$-6.50M
P/E Ratio:
-0.4899
EPS:
-3.7153
Net Cash Flow:
$-6.15M
1W Performance:
+7.06%
1M Performance:
-8.08%
6M Performance:
-51.08%
1Y Performance:
-85.81%
1-Day Range:
$1.81
$1.90
1-Week Range:
$1.70
$2.35
52-Week Range:
$0.97
$13.34
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Name
Cardio Diagnostics Holdings Inc
Sector
Industry
Phone
855-226-9991
Address
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
1.82 | 5.42M | 14,800 | -6.50M | -6.15M | -3.7153 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News
BioMedNewsBreaks — AI Meets Multi-Omics: Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Targets Earlier, More Precise Cardiac Insights - Scott Coop
Cardio Diagnostics Holdings (CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights - Yahoo Finance
Cardio Diagnostics Leverages AI and Biomarkers to Combat Cardiovascular Disease - citybuzz -
Cardio Diagnostics Holdings (NASDAQ: CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights - Barchart.com
CDIO Should I Buy - Intellectia AI
Cardio Diagnostics Holdings (CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and Management - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and Management - TradingView
Why Cardio Diagnostics Holdings (CDIO) is 'One to Watch' - NewMediaWire
Why Cardio Diagnostics Holdings (NASDAQ: CDIO) Is ‘One to Watch’ - TipRanks
Cardio Diagnostics Leverages AI and Epigenetics for Precision Cardiovascular Medicine - citybuzz -
Aug Closing: Is Cardio Diagnostics Holdings Inc Equity Warrant part of any ETFSwing Trade & Verified Short-Term Plans - baoquankhu1.vn
Net current asset value per share of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Is Cardio Diagn (CDIO) Stock Ready to Drop | Price at $1.78, Down 1.38%Fundamental Analysis - Cổng thông tin điện tử Tỉnh Sơn La
Cardio Diagnostics Engages IBN to Enhance Communications Strategy for AI-Powered Cardiovascular Tests - citybuzz -
Cardio Diagnostics Holdings (NASDAQ: CDIO) Engages IBN to Support Corporate Communications Strategy - The Globe and Mail
Aug Rallies: How does Cardio Diagnostics Holdings Inc perform in inflationary periodsWeekly Trade Report & Intraday High Probability Alerts - baoquankhu1.vn
IBN Initiates Coverage of Cardio Diagnostics Holdings Inc. - The Manila Times
Can Cardio Diag (CDIOW) Stock Maintain Growth | Price at $0.01, Down 4.49%Profit Potential - Xã Vĩnh Công
Pullback Watch: How does Cardio Diagnostics Holdings Inc score in quality rankingsPrice Action & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Dividend Watch: What is the earnings history of Cardio Diagnostics Holdings IncEarnings Recap Summary & Precise Buy Zone Tips - baoquankhu1.vn
Aug Catalysts: What is Cardio Diagnostics Holdings Inc Equity Warrants 5 year growth outlookQuarterly Market Summary & Fast Gaining Stock Reports - baoquankhu1.vn
S P Trends: What is Cardio Diagnostics Holdings Inc Equity Warrants 5 year growth outlookDividend Hike & Daily Stock Trend Reports - baoquankhu1.vn
Shorts Report: Can Cardio Diagnostics Holdings Inc ride the EV wave2026 Retail & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Resistance Check: Can Cardio Diagnostics Holdings Inc ride the EV wave2026 WrapUp & Weekly Market Pulse Updates - baoquankhu1.vn
Is Cardio Diagn (CDIO) Stock a Value Play | Price at $2.06, Up 0.74%Stock Ideas - Xã Thanh Hà
Financial Review: Cardio Diagnostics (NASDAQ:CDIO) versus Avidity Biosciences (NASDAQ:RNA) - Defense World
CDIO Stock Analysis: Cardio Diagnostics Holdings Inc. Common stock flat at 2.04 in medtech sector - UBND thành phố Hải Phòng
Cardio Diagnostics (CDIO) director receives 3,205 stock options at $1.95 exercise price - Stock Titan
[Form 4] Cardio Diagnostics Holdings, Inc. Insider Trading Activity - Stock Titan
Cardio Diagnostics (CDIO) director granted 3,205 options at $1.95 - Stock Titan
Cardio Diagnostics director receives option grant | CDIO Insider Trading - Stock Titan
Institution Moves: Will Cardio Diagnostics Holdings Inc benefit from government policyEarnings Risk Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Breakout Move: What is the implied volatility of Cardio Diagnostics Holdings Inc2026 Earnings Impact & Trade Opportunity Analysis - baoquankhu1.vn
Cardio Diagnostics Holdings (CDIO) Is 'One to Watch' - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Is ‘One to Watch’ - tradingview.com
CDIO Technical Analysis & Stock Price Forecast - Intellectia AI
Cardio Diagnostics Expands Access to AI-Powered Cardiovascular Testing with CMS Reimbursement and International Growth - citybuzz -
Aug Intraday: Can Cardio Diagnostics Holdings Inc continue delivering strong returns2026 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Panic Selling: Is Cardio Diagnostics Holdings Inc vulnerable to short sellers2026 Market Trends & Reliable Intraday Trade Alerts - baoquankhu1.vn
Heart Attack Diagnostics Market (2026-2033) | Troponin - openPR.com
Targets Report: Will Absci Corporation benefit from government policy2026 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
Volume Summary: What are Cardio Diagnostics Holdings Incs recent SEC filings showingQuarterly Portfolio Review & Expert Curated Trade Ideas - baoquankhu1.vn
What drove Cardio Diagn (CDIO) Stock higher this week | Price at $1.96, Up 7.10%Community Buy Alerts - Cổng thông tin điện tử Tỉnh Sơn La
Key Factors and Emerging Trends Shaping the Cardiovascular - openPR.com
Bearish Setup: What is Cardio Diagnostics Holdings Inc Equity Warrants 5 year growth outlook2026 Weekly Recap & Real-Time Market Trend Scan - baoquankhu1.vn
CDIO Price Today: Cardio Diagnostics Holdings Inc. Stock Price, Quote & Chart - MEXC Exchange
Insider Sell: What is the dividend yield of Cardio Diagnostics Holdings Inc Equity Warrant2026 Drop Watch & Proven Capital Preservation Tips - baoquankhu1.vn
CDIO SEC FilingsCardio Diagnostics Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Exit Recap: What is the earnings history of Cardio Diagnostics Holdings Inc2026 Chart Watch & Safe Capital Allocation Plans - baoquankhu1.vn
If You Invested $1,000 in Cardio Diagnostics Holdings Inc (CDIO) - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):